MaryBethHumphreyMD
Rheumatology • Oklahoma City, OKAssociate Professor, Medicine, University of Oklahoma College of Medicine
Dr. Humphrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
941 Stanton L Young Blvd
Bseb 306e
Oklahoma City, OK 73104Phone+1 405-271-8001Fax+1 405-271-3191- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Rheumatology, 2001 - 2003- University of California (San Francisco)Residency, Internal Medicine, 1997 - 2001
Baylor College of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - Present
OK State Medical License 2006 - 2024- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- SHIP inhibition mediates select TREM2-induced microglial functions.Gautham S Ramakrishnan, William L Berry, Angela Pacherille, William G Kerr, John D Chisholm, Chiara Pedicone, Mary Beth Humphrey> ;Molecular Immunology. 2024 Apr 12
- The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation.Jeremy S Houser, Maulin Patel, Kyle Wright, Marta Onopiuk, Leonidas Tsiokas, Mary Beth Humphrey> ;Blood Cells, Molecules & Diseases. 2023 Sep 1
- 1 citationscontrols kidney resident macrophage heterogeneity.Alex Yashchenko, Sarah J Bland, Cheng J Song, Ummey Khalecha Bintha Ahmed, Rachel Sharp, Isabella G Darby, Audrey M Cordova, Morgan E Smith, Jeremie M Lever, Zhang Li,...> ;Frontiers in Immunology. 2023 Jan 1
- Join now to see all
Press Mentions
- ACR Convergence 2022 – PhiladelphiaNovember 20th, 2022
American College of Rheumatology Updates GIOP Treatment GuidelineOctober 17th, 2022- Docs Gain New Flexibility Treating Osteoporosis from SteroidsSeptember 23rd, 2022
- Join now to see all
Grant Support
- Understanding The Role Of Alternative Splicing In The TNFAIP3 Sle-Risk AllelesNational Center For Research Resources2010–2011
- Mechanism Of ITAM Signal Regulation In OsteoclastsNational Institute Of Dental &Craniofacial Research2008–2011
- SHIP1 Regulation Of DAP12 In Osteoclast Development And FunctionNational Center For Research Resources2007–2009
Hospital Affiliations
- Grady Memorial HospitalChickasha, Oklahoma
OU HealthOklahoma City, Oklahoma
Oklahoma City VA Medical CenterOklahoma City, Oklahoma
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
